These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12079822)

  • 1. Wider use for implantable defibrillators.
    Harv Heart Lett; 2002 Jun; 12(10):4-5. PubMed ID: 12079822
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of arrhythmias and use of implantable cardioverter-defibrillators to improve survival in elderly patients with cardiac disease.
    Goldenberg I; Moss AJ
    Clin Geriatr Med; 2007 Feb; 23(1):205-19. PubMed ID: 17126763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and misuse of surrogate outcomes in arrhythmia trials.
    Connolly SJ
    Circulation; 2006 Feb; 113(6):764-6. PubMed ID: 16476858
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of implantable cardioverter-defibrillators: from trials to the real world.
    De Sousa J
    Rev Port Cardiol; 2005 Apr; 24(4):501-4. PubMed ID: 15977774
    [No Abstract]   [Full Text] [Related]  

  • 5. NHLBI stops arrhythmia study: implantable cardiac defibrillators reduce deaths.
    Circulation; 1997 Jun; 95(11):2465. PubMed ID: 9184572
    [No Abstract]   [Full Text] [Related]  

  • 6. [The MADIT-RIT study].
    Proclemer A; Locati ET
    G Ital Cardiol (Rome); 2013 Apr; 14(4):241-5. PubMed ID: 23567763
    [No Abstract]   [Full Text] [Related]  

  • 7. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy.
    Reynolds MR; Josephson ME
    Circulation; 2003 Oct; 108(15):1779-83. PubMed ID: 14557341
    [No Abstract]   [Full Text] [Related]  

  • 8. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimizing right ventricular pacing.
    Barold SS; Herweg B; Sweeney MO
    Am J Cardiol; 2005 Apr; 95(8):966-9. PubMed ID: 15820164
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for cardiac arrhythmias.
    Treat Guidel Med Lett; 2004 Nov; 2(27):75-82. PubMed ID: 15529117
    [No Abstract]   [Full Text] [Related]  

  • 11. T-wave alternans in the sudden cardiac death in heart failure trial population: signal or noise?
    Rosenbaum DS
    Circulation; 2008 Nov; 118(20):2015-8. PubMed ID: 19001031
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of the implantable cardioverter defibrillator.
    Cannom DS; Prystowsky EN
    J Cardiovasc Electrophysiol; 2004 Mar; 15(3):375-85. PubMed ID: 15030435
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical research designs and implantable defibrillator indications: spend in the beginning or pay at the end.
    Myerburg RJ; Castellanos A
    J Am Coll Cardiol; 2006 Jan; 47(1):108-11. PubMed ID: 16386672
    [No Abstract]   [Full Text] [Related]  

  • 14. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICD therapy: what have we learned from the clinical trials?
    Arya A; Haghjoo M; Sadr-Ameli MA
    Heart Lung Circ; 2006 Feb; 15(1):3-11. PubMed ID: 16473784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Emergencies in patients with implanted pacemakers or defibrillators].
    Buob A; Neuberger HR; Böhm M; Mewis C
    Dtsch Med Wochenschr; 2008 Jun; 133(23):1253-8. PubMed ID: 18509803
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiarrhythmic effects of statins in heart failure.
    Sandesara CM; Roodneshin H; Sbaity S; Olshansky B
    Heart Fail Clin; 2008 Apr; 4(2):187-200. PubMed ID: 18433699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
    McDowell DL; Hauptman PJ
    J Heart Lung Transplant; 2009 Aug; 28(8):847-50. PubMed ID: 19632584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of arrhythmias by implantable automatic defibrillators].
    Fromer M
    Rev Med Suisse Romande; 1999 May; 119(5):395-7. PubMed ID: 10384774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.